ALK-POSITIVE BONE CANCER

Clinical trials for ALK-POSITIVE BONE CANCER explained in plain language.

Never miss a new study

Get alerted when new ALK-POSITIVE BONE CANCER trials appear

Sign up with your email to follow new studies for ALK-POSITIVE BONE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New hope for rare bone cancer: targeted pills aim to stop tumor growth

Disease control Not yet recruiting

This early-phase trial tests two targeted drugs, crizotinib and alectinib, in people with a rare form of advanced bone cancer that has a specific genetic change (truncated ALK). The study enrolls about 10 adults whose cancer has worsened after standard treatment or who have no go…

Matched conditions: ALK-POSITIVE BONE CANCER

Phase: PHASE1, PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control

Last updated May 26, 2026 10:26 UTC

ALK-POSITIVE BONE CANCER

Get alerted when new ALK-POSITIVE BONE CANCER trials appear

New hope for rare bone cancer: targeted pills aim to stop tumor growth